The global intellectual property landscape of induced pluripotent stem cell technologies

MacKenna Roberts; Ivan B Wall; Ian Bingham; Dominic Icely; Brock Reeve; Kim Bure; Anna French; David A Brindley

doi:10.1038/nbt.2975

The global intellectual property landscape of induced pluripotent stem cell technologies

MacKenna Roberts
, Ivan B Wall
, Ian Bingham
, Dominic Icely
, Brock Reeve
, Kim Bure
, Anna French
, David A Brindley

Harvard Stem Cell Institute, Cambridge, MA 02138, USA; The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation, University of Oxford, Oxford, OX3 9DU, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, Oxford, OX3 7LD, UK; Centre for Behavioural Medicine, UCL School of Pharmacy, University College London, London WC1H 9JP, UK.
IP Asset LLP, Oxford, UK.
Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation and Harvard Stem Cell Institute, Cambridge, Massachusetts; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA; Saïd Business School, University of Oxford, Oxford, United Kingdom; Centre for Behavioural Medicine, UCL School of Pharmacy, University College London, London, United Kingdom; Stanford-UCSF FDA Center of Excellence in Regulatory Science and Innovation (CERSI), San Francisco, Cali
Sartorius Stedim, Göttingen, Germany.
Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, University of Oxford
Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, University of Oxford, Oxford, UK.

Research output: Contribution to journal › Article › peer-review

39 Citations (Scopus)

Original language	English
Pages (from-to)	742–748
Number of pages	7
Journal	Nature Biotechnology
Volume	32
Issue number	8
DOIs	https://doi.org/10.1038/nbt.2975
Publication status	Published - 5 Aug 2014

Keywords

Biotechnology
Induced Pluripotent Stem Cells
Intellectual Property
Internationality
Patents as Topic

Access to Document

10.1038/nbt.2975

Cite this

@article{a705b03d0b9a483c9554153fbbc5a5ae,

title = "The global intellectual property landscape of induced pluripotent stem cell technologies",

keywords = "Biotechnology, Induced Pluripotent Stem Cells, Intellectual Property, Internationality, Patents as Topic",

author = "MacKenna Roberts and Wall, \{Ivan B\} and Ian Bingham and Dominic Icely and Brock Reeve and Kim Bure and Anna French and Brindley, \{David A\}",

year = "2014",

month = aug,

day = "5",

doi = "10.1038/nbt.2975",

language = "English",

volume = "32",

pages = "742–748",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Research",

number = "8",

}

TY - JOUR

T1 - The global intellectual property landscape of induced pluripotent stem cell technologies

AU - Roberts, MacKenna

AU - Wall, Ivan B

AU - Bingham, Ian

AU - Icely, Dominic

AU - Reeve, Brock

AU - Bure, Kim

AU - French, Anna

AU - Brindley, David A

PY - 2014/8/5

Y1 - 2014/8/5

KW - Biotechnology

KW - Induced Pluripotent Stem Cells

KW - Intellectual Property

KW - Internationality

KW - Patents as Topic

UR - https://www.nature.com/articles/nbt.2975

U2 - 10.1038/nbt.2975

DO - 10.1038/nbt.2975

M3 - Article

C2 - 25093884

SN - 1087-0156

VL - 32

SP - 742

EP - 748

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 8

ER -

The global intellectual property landscape of induced pluripotent stem cell technologies

Keywords

Access to Document

Other files and links

Cite this